SCHEMBL23025720

SCHEMBL23025720

CCOC(=O)c1nn[nH]c1C

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 1/20 0.50
KDM4E B2RXH2 4/20 0.45
POLB P06746 1/20 0.44
CYP1A2 P05177 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPT P10636 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
TP53 P04637 1/20 0.40
ALOX12 P18054 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
DPP4 P27487 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7277080 0.83 PDE4D (0.44) PDE4DKDM4EPOLBCYP1A2MEN1
SCHEMBL5648877 0.83 KDM4E (0.46) PDE4DKDM4EPOLBCYP1A2MEN1
SCHEMBL1928112 0.83 PDE4D (0.44) PDE4DKDM4EPOLBCYP1A2MEN1
SCHEMBL7764111 0.82 LMNA (0.48) KDM4EPOLBMAPTTSHRALDH1A1
SCHEMBL5906562 0.81 PDE4D (0.43) PDE4DKDM4EPOLBCYP1A2MEN1
SCHEMBL11368014 0.81 ALDH1A1 (0.50) PDE4DKDM4EPOLBCYP1A2MEN1
SCHEMBL15897055 0.81 PDE4D (0.43) PDE4DKDM4EPOLBCYP1A2MEN1
SCHEMBL1412491 0.80 PDE4D (0.42) PDE4DKDM4EPOLBCYP1A2MEN1
SCHEMBL5648880 0.80 KDM4E (0.47) PDE4DKDM4EPOLBCYP1A2MEN1
SCHEMBL11528604 0.80 PDE4D (0.42) PDE4DKDM4EPOLBCYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025124460-A1 TRICYCLIC FUSED HETEROCYCLIC PDE3/4 DUAL INHIBITOR, AND PREPARATION AND USE THEREFOR 石家庄以岭药业股份有限公司 2025-06-19 WO disclosed
WO-2021035196-A1 COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES OXALURX, INC. (US) 2021-02-25 WO disclosed